Engineered immune cells aim to deepen remission in stubborn myeloma
NCT ID NCT05032820
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 25 times
Summary
This study tested a one-time treatment using the patient's own immune cells, engineered to target and kill myeloma cells. It involved 40 adults with multiple myeloma who had a weak response to a stem cell transplant and ongoing maintenance therapy. The goal was to see if this cell therapy could achieve a complete or better remission by 6 months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Baylor College and Medicine
Houston, Texas, 77030, United States
-
Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02215, United States
-
City of Hope National Medical Center
Duarte, California, 91010, United States
-
Duke University Medical Center
Durham, North Carolina, 27705, United States
-
H. Lee Moffitt Cancer Center
Tampa, Florida, 33612, United States
-
Loyola University Medical Center
Maywood, Illinois, 60153, United States
-
Medical College of Wisconsin
Milwaukee, Wisconsin, 53226, United States
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
-
Mount Sinai Medical Center
New York, New York, 10029, United States
-
Roswell Park Cancer Center
Buffalo, New York, 14203, United States
-
Stanford Hospital and Clinics
Palo Alto, California, 94305, United States
-
University of California, San Francisco
San Francisco, California, 94143, United States
-
University of Pennsylvania Hospital Center
Philadelphia, Pennsylvania, 19104, United States
-
University of Virginia
Charlottesville, Virginia, 22908, United States
-
University of Wisconsin Hospitals and Clinics
Madison, Wisconsin, 53792, United States
Conditions
Explore the condition pages connected to this study.